Take a look back at the 2023 conference, hosted by the University of Calgary and McMaster University, and held in Banff, Alberta, Canada.
The International Oncolytic Virotherapy Conference (IOVC) launched more than 20 years ago at the inaugural meeting in Rochester, Minnesota, hosted by the Mayo Clinic. Since then, a passionate group of scientists and clinicians has embarked on a mission to establish a world-class Oncolytic Virus Therapy Conference, bringing together clinicians, academic researchers, and biotech companies in the field.
This year the conference was hosted by the University of Calgary and McMaster University and held in Banff, Alberta, Canada.
The conference enables sharing and discussing the advancements in oncolytic virus approaches and provides a global stage for researchers to showcase their work and explore international collaborations while enabling pharmaceutical companies to access the cutting-edge research happening in small biotech and academic labs, in an atmosphere where the free exchange of scientific knowledge is cultivated, and discussion remains unbiased and academic.
Many of Alliance for Cancer Gene Therapy’s Scientific Advisory Committee members and Research Fellows participated in the conference, including:
Additional ACGT Scientific Advisory Committee members and Research Fellows who participated in the conference included: Joseph C. Glorioso, III, PhD, of the University of Pittsburgh; Kah Whye Peng, PhD, of Mayo Clinic; and Douglas Mahoney, PhD, of the University of Calgary.
Other clinical trial presentations of note included:
During the closing dinner of the conference, Dr. Russell presented Dr. Chiocca with the “Golden Virus Award” for outstanding leadership in the oncolytic virus field.
Considerations for Administering Hemoglobinopathy Gene Therapies From a Pharmacist’s Perspective
April 20th 2024Alexis Kuhn, PharmD, BCOP, a pediatric oncology pharmacist at Mayo Clinic, discussed the incorporation of the recently FDA-approved gene therapies for SCD and TDT into the work of pharmacists.